Huntington's Disease

Huntington's disease (HD) is a complex neurological condition that has a profound impact on the lives of those affected and their loved ones. This inherited disorder is caused by a genetic mutation that leads to the progressive deterioration of brain cells, particularly in regions responsible for controlling voluntary movements and cognition. As the disease progresses, individuals with HD experience a wide range of symptoms that can significantly affect their daily functioning and overall quality of life. Understanding the causes, symptoms, and available support options is crucial for those facing the challenges of Huntington's disease.

What is Huntington's Disease?

Huntington's disease is a neurodegene1rrative disorder that causes the progressive breakdown of nerve cells in the brain. The condition is caused by a mutation in the huntingtin (HTT) gene, which provides instructions for making a protein called huntingtin. The mutated gene produces an abnormal form of the protein, which accumulates in the brain and disrupts normal brain function. As the disease progresses, it leads to increasingly severe symptoms that affect a person's physical, mental, and emotional well-being. While there is currently no cure for Huntington's disease, treatments are available to help manage symptoms and improve quality of life.

Huntington's disease is categorised into two main types based on age of onset, including:

• Adult-Onset Huntington's Disease: Adult-onset HD typically appears between ages 30 and 50. Initial symptoms include mood changes, concentration difficulties, and involuntary movements (chorea). As it progresses, individuals face severe motor, cognitive, and emotional decline, usually over 15 to 20 years. 
• Juvenile Huntington's Disease: Juvenile HD occurs in individuals under 20. Symptoms include severe motor dysfunction, cognitive decline, and behavioural changes, and progression is often more rapid than adult-onset HD. Early diagnosis and intervention are crucial for effective management (Huntington Study Group, 2024). 

The early signs of Huntington's disease may include:

• Challenges with attention and focus  
• Episodes of forgetfulness  
• Depression, including feelings of sadness and hopelessness
• Frequent stumbling  
• Emotional fluctuations, such as irritability or aggressive outbursts  

The symptoms of Huntington's disease can vary from person to person, including:

• Chorea: Chorea involves involuntary jerking or twitching movements that can affect various body parts. These movements are irregular and can be sudden, making daily tasks and fine motor skills challenging.
• Balance Issues: People with HD often struggle with walking, posture, and movement coordination. This clumsiness and balance issues can cause frequent falls and make simple tasks, like reaching for objects or moving through spaces, more difficult.
• Rigidity: Muscle stiffness, or rigidity, is common in HD and may be more severe in juvenile cases. This stiffness can restrict movement and lead to discomfort and difficulty with voluntary actions.
• Dysphagia: Dysphagia refers to problems with swallowing, which can lead to difficulties with eating and significant weight loss. This condition increases the risk of choking and aspiration pneumonia (lung infection), requiring careful dietary management.
• Speech Difficulties: In HD, speaking clearly is often challenging, with speech becoming slurred or slow. These issues can hinder effective communication, making it harder for individuals to express themselves and participate in conversations.
• Depression: Depression is common in people with HD and may arise from changes in the brain. Antidepressants such as SSRIs or SNRIs may be used for management (Saft et al., 2023). This mood disorder can impact emotional well-being and overall quality of life.
• Mood Swings and Personality Changes: HD often causes increased irritability, aggression, and hostility. These mood swings and personality changes can affect relationships and social interactions, adding to the emotional burden of the disease.
• Obsessive-Compulsive Behaviours: Some individuals with HD develop obsessive-compulsive behaviours, characterised by repetitive thoughts and actions. These behaviours can interfere with daily functioning and quality of life.
• Social Withdrawal: Social withdrawal is a common symptom, with individuals becoming increasingly isolated or disengaged from social interactions.
• Memory Loss: Difficulty recalling information and experiences is a significant cognitive symptom of HD. Memory loss can affect both short-term and long-term recall, complicating everyday activities and decision-making.
• Difficulty Concentrating: Challenges with concentration make it difficult for individuals to focus on tasks and make decisions.
• Cognitive Decline: Over time, HD leads to significant cognitive impairment, potentially progressing to dementia. This decline affects a range of cognitive functions, including memory, judgement, and problem-solving abilities, significantly impacting daily life.

Huntington's disease progresses through distinct stages, each characterised by specific challenges. These include:

• Stage I (0 to 8 years from illness onset): In stage I, individuals may experience subtle behavioural changes and mild motor symptoms. This stage is often characterised by a lack of awareness about the disease, leading to initial confusion and frustration as the symptoms begin to manifest.
• Stage II (3 to 13 years from illness onset): During stage II, symptoms become more pronounced, including mood swings and difficulties with coordination. Individuals may struggle with daily tasks, and this stage often involves increased emotional strain on both patients and their families as they adapt to these changes.
• Stage III (5 to 16 years from illness onset): Stage III is marked by significant cognitive and motor decline. Individuals may experience involuntary movements, memory loss, and challenges in communication. This stage can create additional emotional distress, necessitating greater support from caregivers and loved ones.
• Stage IV (9 to 21 years from illness onset): In stage IV, individuals face severe limitations in mobility and cognitive function. Daily activities become increasingly challenging, requiring extensive assistance. This stage emphasises the need for patience and support as both patients and caregivers navigate the complexities of advanced HD.
• Stage V (11 to 26 years from illness onset): The final stage of HD often involves profound physical and cognitive impairment, leading to complete dependence on caregivers. Quality of life becomes a primary focus as families seek to provide comfort and dignity for their loved ones during this advanced stage of the disease.

The causes of Huntington's disease involve specific genetic and molecular changes, including:

• Genetic Mutation: Huntington's disease is caused by a mutation in the HTT gene on chromosome 4, resulting in an abnormal form of the huntingtin protein.
• CAG Repeats: The mutation involves an expanded CAG repeat sequence in the HTT gene. While the normal sequence is repeated approximately 10 to 35 times, in Huntington's disease, it is repeated 36 or more times.
• Inherited Condition: Huntington's disease is inherited in an autosomal dominant pattern, meaning that inheriting one copy of the mutated gene from either parent will cause the disease. Each child of an affected parent has a 50% chance of inheriting the mutation.
• Protein Aggregation: The abnormal huntingtin protein forms toxic aggregates in brain cells, disrupting their normal function and leading to damage.
• Neuronal Death: These toxic protein aggregates cause progressive neuronal death, particularly in the basal ganglia and cortex, leading to the characteristic motor, cognitive, and psychiatric symptoms of the disease.

The risk factors of Huntington's disease include:

• Genetic mutation in the HTT gene
• Family history of Huntington's disease
• Age of onset (typically 30–50 years)
• Autosomal dominant inheritance pattern
• Expansion of CAG repeats in the HTT gene

Who's at Risk?

People at risk for Huntington's disease typically include:

• Individuals with a parent who has Huntington's disease
• Those with a known mutation in the HTT gene
• People with a family history of the disease
• Siblings of affected individuals

It is important to note that having a family history of Huntington's disease does not necessarily mean that an individual will develop the condition. However, those at risk may consider genetic testing and counselling to make informed decisions about their health and future.

Huntington's disease can lead to a range of complications that significantly impact an individual's quality of life. These include:

• Chorea and Dyskinesia: Huntington's disease often leads to chorea (involuntary movements) and dyskinesia (abnormal, uncontrolled movements), which can significantly impair daily functioning and quality of life.
• Cognitive Decline and Dementia: Progressive cognitive decline in HD can lead to dementia, affecting memory, reasoning, and problem-solving abilities, severely impacting independence and daily activities.
• Depression and Anxiety: Many individuals with HD experience depression and anxiety, which can exacerbate emotional distress and complicate overall disease management.
• Swallowing Difficulties and Aspiration Pneumonia: Problems with swallowing (dysphagia) increase the risk of aspiration pneumonia, a serious condition where food or liquid enters the lungs, leading to infections.
• Weight Loss and Malnutrition: Weight loss and malnutrition are common due to difficulties with eating and increased energy expenditure, which can lead to further health complications.
• Falls and Injuries: Balance issues and coordination problems increase the risk of falls and related injuries, which can further affect mobility and safety.
• Sleep Disorders: Sleep disturbances, such as insomnia and frequent waking, are common and can affect overall health and increase fatigue.
• Behavioural Problems: Behavioural issues, including aggression and irritability, can strain relationships and complicate social interactions, impacting the quality of life for both patients and caregivers.

Currently, there is no known way to prevent Huntington's disease due to its genetic nature. However, some strategies can be considered:

• Genetic Counselling and Testing: Individuals with a family history of Huntington's disease may benefit from genetic counselling to understand their risk and options. Genetic testing can determine if someone carries the mutated HTT gene.
• Family Planning: For those at risk, family planning options such as preimplantation genetic diagnosis (PGD) can help prevent passing the mutation to future generations by selecting embryos without the gene mutation.
• Research Participation: Participating in research studies and clinical trials may provide access to new treatments and contribute to the development of potential preventive measures.
• Early Intervention: Early diagnosis and intervention can help manage symptoms more effectively and improve the quality of life, though this does not prevent the disease itself.

Diagnosing Huntington's disease typically involves a combination of several steps:

• Clinical Examination: Your doctor will perform a detailed physical and neurological exam to assess your motor abilities and cognitive functions.
• Family History: Having a family history of Huntington's disease is often the biggest clue in diagnosing the condition.
• Genetic Testing: A blood test can confirm the diagnosis by identifying the presence of the mutated HTT gene.
• Imaging Tests: Computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, or positron emission tomography (PET) scans may be used to evaluate brain damage and tissue loss associated with Huntington's disease.

Early signs of Huntington's disease may include subtle changes in coordination, involuntary movements (chorea), difficulty concentrating or remembering information, depression, and mood swings. If you notice any of these symptoms, especially if you have a family history of the condition, consult your doctor for further evaluation.

1. Motor Symptom Control with VMAT2 Inhibitors

Involuntary movements such as chorea are hallmark motor features of Huntington’s disease. These symptoms can interfere with mobility, balance, and daily activities. Vesicular monoamine transporter 2 (VMAT2) inhibitors help control these excessive movements.

• Tetrabenazine: Reduces the release of dopamine in the brain, helping to suppress chorea.
• Deutetrabenazine: A newer, longer-acting alternative with improved tolerability and fewer side effects.
• Valbenazine: May be considered in some cases, although it is not specifically approved for Huntington’s disease chorea.

VMAT2 inhibitors help control chorea and other involuntary movements. They are most effective when carefully dose-adjusted based on patient response to minimise side effects and should be combined with other therapies as needed for optimal symptom control, (Saft et al., 2023).

2. Antipsychotic Medications for Behavioural Symptoms

Psychiatric and behavioural symptoms such as aggression, irritability, mood instability, and hallucinations may significantly impact patient care and family dynamics. Antipsychotic medications are often used to manage these challenges.

• Haloperidol: A typical antipsychotic helpful in controlling severe agitation and aggression.
• Olanzapine: An atypical antipsychotic that may address both behavioural and choreiform symptoms.
• Fluphenazine: Offers long-term behavioural stabilisation with depot (long-acting) options for difficult cases.

Antipsychotic treatment helps to:

• Reduce aggression and improve interpersonal interactions
• Minimise paranoia, delusions, or hallucinations
• Stabilise mood in those with co-occurring psychosis or severe mood swings
• Improve care compliance and reduce caregiver stress

3. Regular Physical Therapy

Engaging in consistent physical therapy helps maintain strength, flexibility, balance, and mobility. It plays a key role in delaying functional decline and supporting everyday functioning.

4. Speech Therapy for Communication

As speech and swallowing difficulties emerge, speech therapy is valuable in preserving communication skills and ensuring safe swallowing techniques to reduce the risk of aspiration.

5. Cognitive Therapy for Mental Functioning

Cognitive therapy is introduced to support cognitive function and slow the progression of symptoms, helping patients manage daily activities with greater independence.

6. Nutritional Support

Due to the increased energy demands and difficulties with eating, a high-calorie, nutritious diet is advised. Dietitians may recommend texture-modified foods and supplements to prevent weight loss.

7. Psychological and Emotional Counselling

Ongoing counselling helps patients with this condition and their families cope with the emotional challenges of the disease, including depression, anxiety, and grief associated with progressive decline.

Living with Huntington's disease presents significant challenges as the condition progresses. This may include:

• The need for constant assistance and supervision due to the debilitating effects of the disease.
• A decline in health typically occurs within 15 to 20 years after symptoms first appear.
• The importance of maintaining physical fitness if diagnosed with or at risk for the disease.
• Engaging in regular exercise and staying active to enhance overall well-being.
• Active individuals generally experience better outcomes compared to those who are sedentary.

If you have been diagnosed with Huntington's disease, it is crucial to maintain regular follow-up appointments with your doctor to closely monitor your condition. Seek immediate medical attention if you experience worsening symptoms, such as increasing difficulty with motor tasks like walking or balance, trouble swallowing or choking while eating, significant mood changes, including depression or suicidal thoughts, rapid weight loss or difficulty maintaining a healthy weight, or severe behavioural changes and agitation. Your doctor can assess these symptoms, adjust your treatment plan as needed, and offer guidance on managing the disease effectively. They may also refer you to specialists such as neurologists, psychiatrists, or physical therapists to address specific aspects of your care. Remember, early intervention and consistent medical care are essential for maintaining the best possible quality of life when living with Huntington's disease.

• Huntington's disease is a genetic disorder characterised by movement disorders, cognitive decline, and psychiatric symptoms.
• The disease is caused by a defective gene that leads to the production of an abnormal protein, which accumulates in the brain and causes damage to nerve cells.
• Early signs of Huntington's disease may include subtle changes in mood, cognition, and motor skills.
• The diagnosis of Huntington's disease involves genetic testing, neurological examinations, and brain imaging.
• There is currently no cure for Huntington's disease, but medications and supportive therapies can help manage symptoms, improve quality of life, and may slow disease progression with emerging disease-modifying treatments (Tabrizi et al., 2025).
• Dopamine-depleting agents and anticonvulsants are commonly used to manage chorea and muscle spasms, while dopamine receptor antagonists can be used as second-line therapy for chorea relief.
• Early diagnosis and appropriate treatment can significantly improve the quality of life for patients with Huntington's disease.
• Regular follow-up appointments with doctors are essential to monitor the progression of the disease and adjust treatment as needed.